Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment ; volume:13 ; number:1 ; day:19 ; month:10 ; year:2018 ; pages:1-10 ; date:12.2018
Radiation oncology ; 13, Heft 1 (19.10.2018), 1-10, 12.2018
- Urheber
-
Clemente, Stefania
- Beteiligte Personen und Organisationen
-
Oliviero, Caterina
Palma, Giuseppe
D’Avino, Vittoria
Liuzzi, Raffaele
Conson, Manuel
Pacelli, Roberto
Cella, Laura
SpringerLink (Online service)
- DOI
-
10.1186/s13014-018-1146-3
- URN
-
urn:nbn:de:101:1-2018112622145482024421
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Clemente, Stefania
- Oliviero, Caterina
- Palma, Giuseppe
- D’Avino, Vittoria
- Liuzzi, Raffaele
- Conson, Manuel
- Pacelli, Roberto
- Cella, Laura
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma